Article Information
History
- November 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eleonora Porcu1,2,+,
- Federica Gilardi3,4,+,
- Liza Darrous5,2,
- Loic Yengo6,
- Nasim Bararpour3,4,
- Marie Gasser3,4,
- Pedro Marques Vidal7,
- Philippe Froguel8,9,
- Gerard Waeber7,
- Aurelien Thomas3,4,* and
- Zoltán Kutalik5,2,*
- 1Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
- 2Swiss Institute of Bioinformatics, Lausanne, Switzerland
- 3Unit of Forensic Toxicology and Chemistry, CURML, Lausanne University Hospital and Geneva University Hospitals, Geneva, Switzerland
- 4Faculty Unit of Toxicology, CURML, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
- 5Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland
- 6Institute for Molecular Bioscience, The University of Queensland; Brisbane, Australia
- 7Department of Medicine, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 8Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Université de Lille, Institut Pasteur de Lille, Lille University Hospital, Lille, France
- 9Department of Metabolism, Imperial College London, London, UK
Posted November 03, 2020.
Identification of metabolomics biomarkers for type 2 diabetes: triangulating evidence from longitudinal and Mendelian randomization analyses
